Page last updated: 2024-12-07

poly-o-acetylserine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

O-acetylserine: RN given refers to (DL)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

O-acetyl-L-serine : An acetyl-L-serine where the acetyl group is attached to the side-chain oxygen. It is an intermediate in the biosynthesis of the amino acid cysteine in bacteria. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID99478
CHEMBL ID1234916
CHEBI ID17981
SCHEMBL ID598363
MeSH IDM0051711

Synonyms (38)

Synonym
CHEMBL1234916
CHEBI:17981 ,
l-serine, acetate (ester)
nsc-226230
C00979
o-acetyl-l-serine
o-acetylserine
o3-acetyl-l-serine
5147-00-2
DB01837
C7F78DD0-90DD-465D-AEB8-524F58E72B51
serine, o-acetyl-
(2s)-3-acetyloxy-2-aminopropanoic acid
AKOS006238075
BMSE000983
unii-g05l7t7zeq
nsc 226230
g05l7t7zeq ,
(s)-3-acetoxy-2-aminopropanoic acid
25248-96-8
OAS ,
l-serine, o-acetyl-
o-ac-l-ser-oh
S6144
SCHEMBL598363
VZXPDPZARILFQX-BYPYZUCNSA-N
(2s)-3-(acetyloxy)-2-aminopropanoic acid
mfcd00037771
o-acetyl-l-serine (h-l-ser(ac)-oh)
AC-9103
o-acetyl-serine
o-acetyl-l-ser
HY-101409
CS-6301
DTXSID20904718
Q309897
AS-10491
A913073
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
acetyl-L-serineAn acetyl-amino acid in which the amino acid specified is L-serine.
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (5)

PathwayProteinsCompounds
Mycobacterium tuberculosis biological processes3962
Sulfur compound metabolism1929
Cysteine synthesis from O-acetylserine715
cysteine biosynthesis I08
Biochemical pathways: part I0466
Cysteine biosynthesis I07

Research

Studies (84)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (5.95)18.7374
1990's16 (19.05)18.2507
2000's30 (35.71)29.6817
2010's27 (32.14)24.3611
2020's6 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.54 (24.57)
Research Supply Index4.44 (2.92)
Research Growth Index4.98 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other80 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]